Will Rising Healthcare Costs in the United States Become Unmanageable, or Can Policy Changes Make Care More Affordable?

By: Grishma Sonawane

As healthcare costs continue to rise in the United States, affordability has become a growing concern for both individuals and policymakers. The U.S. spends more per person on healthcare than any other developed nation, yet many Americans still struggle to afford even basic medical services. According to the Commonwealth Fund, “the U.S. spends nearly twice as much per capita on health care as other wealthy nations” (Woskie & Jha, 2019). Despite this high level of spending, outcomes do not necessarily improve. In fact, the Peterson Foundation reports that “despite spending more on healthcare, the U.S. has the lowest life expectancy among comparable countries” (Wang & Xiang, 2024). This raises an important question: Will rising healthcare costs continue to worsen, or can government policies and global models help make care more affordable in the future? Although the United States has one of the most advanced healthcare systems in the world, research shows that high costs are largely driven by pricing rather than quality or usage. As a result, stronger government regulation and lessons from foreign healthcare systems may be necessary to control long-term costs and improve access to care. Healthcare affordability is not just a personal issue; it is a national one with long-term economic consequences. When individuals cannot afford care, they often delay treatment, which can lead to more serious health conditions and higher costs later. This cycle increases financial strain on both families and the healthcare system. A study published in JAMA found that “prices, not higher usage, drive U.S. health care costs” (Papanicolas et al., 2018). This finding directly challenges the assumption that Americans use more healthcare services and instead highlights how the lack of price regulation creates major financial barriers.

One possible solution to rising costs is stronger government regulation. Supporters of this approach argue that implementing price controls, especially for pharmaceuticals and hospital services, could significantly reduce healthcare spending. The Commonwealth Fund explains that countries such as Australia, Germany, and the Netherlands “keep health care affordable through strict price regulations and government negotiated rates” (Woskie & Jha, 2019). These systems demonstrate that government involvement does not eliminate innovation, but instead helps balance cost, access, and quality. However, adopting similar policies in the United States is challenging due to political resistance and strong pharmaceutical industry influence. Even so, international evidence suggests that regulation remains one of the most effective tools for long-term cost control. In addition to regulation, foreign healthcare systems provide valuable insight into how the U.S. could improve affordability. Data from the Organisation for Economic Co-operation and Development (OECD) shows that “countries where the government pays more for healthcare usually have lower costs” (OECD, 2023). This directly contradicts the common belief that government involvement increases spending. In reality, these systems are often more efficient and better equipped to handle economic challenges such as inflation.

Germany’s healthcare system offers a strong example of how cost control and access can be balanced. According to Aim Alliance, Germany uses a “universal multi-payer system where healthcare is mandatory, and costs are shared between employers and employees” (Aim Alliance, 2022). This model combines private insurance with government regulation, creating a system that maintains patient choice while controlling costs. Germany’s success suggests that the U.S. does not need to fully eliminate private healthcare to achieve more affordable outcomes. Another key difference between the U.S. and other countries is access to care. The Commonwealth Fund’s Mirror, Mirror report found that “adults in the U.S. are far more likely than those in comparable countries to skip needed medical care due to cost” (Gumas et al., 2024). In countries with universal or near-universal coverage, patients are more likely to receive early treatment, which prevents chronic conditions from worsening and reduces overall healthcare spending. The World Health Organization also emphasizes that universal coverage “stops families from going broke because of medical bills” (WHO, 2023), highlighting the broader economic benefits of accessible healthcare systems. While foreign healthcare models cannot be copied exactly due to differences in population size, political structure, and funding systems, they still provide important lessons. These systems consistently show that prioritizing affordability and access leads to better health outcomes and more sustainable costs over time.

After examining multiple perspectives, it becomes clear that rising healthcare costs in the United States are not just an individual burden but a widespread national issue. Although experts may disagree on the best solution, most agree that the current system is too expensive and inefficient. Some emphasize the need for stronger government regulation, while others focus on adapting successful strategies from foreign healthcare systems. However, the most convincing argument is that price control—especially in pharmaceuticals and hospital services is essential for meaningful reform. The evidence strongly supports this conclusion. The JAMA study confirms that “high prices for medicine, doctor visits, and hospital care” (Papanicolas et al., 2018) are the main drivers of U.S. healthcare costs. Without directly addressing these pricing issues, other reforms are unlikely to significantly improve affordability. Similarly, the Commonwealth Fund shows that countries with negotiated pricing systems consistently achieve lower costs without sacrificing quality (Woskie & Jha, 2019).

In conclusion, rising healthcare costs in the United States will likely continue to create financial challenges unless significant policy changes are made. While the system offers advanced medical care, its high prices make it inaccessible for many Americans. Research shows that stronger government regulation and lessons from foreign healthcare systems could help control costs and expand access. Moving forward, policymakers must focus on reducing prices and improving coverage in order to create a more affordable and equitable healthcare system.